Form 4 Tracker
GeneDx Holdings Corp.
WGS

21 insider filings · Latest: May 7, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 9, 2024Dec 10 1:05 AMKatherine Stueland
Proposed Sale
3,661$76.37$279.6K

View →

Dec 2, 2024Dec 3 1:01 AMKevin Feeley
Proposed Sale
263$78.39$20.6K

View →

Nov 21, 2024Nov 21 11:14 PMFeeley Kevin
Proposed Sale
22,000$72.73$1.6M

View →

Nov 19, 2024Nov 19 10:10 PMRyan Jason
Proposed Sale
47,000$70.00$3.3M

View →

Nov 15, 2024Nov 15 9:58 PMStueland Katherine
Proposed Sale
45,415$70.02$3.2M

View →

Oct 31, 2024Nov 1 12:03 AMICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Proposed Sale
1,012,941$81.69$82.7M

View →

Oct 29, 2024Oct 29 11:45 PMKevin Feeley
Proposed Sale
274$66.60$18.2K

View →

Oct 29, 2024Oct 29 11:44 PMKatherine Stueland
Proposed Sale
2,154$66.60$143.5K

View →

Sep 17, 2024Sep 20 6:56 PMOPKO HEALTH, INC.
Proposed Sale
13,404$40.88$548.0K

View →

Sep 16, 2024Sep 16 10:54 PMKevin Feeley
Proposed Sale
2,635$37.59$99.0K

View →

Sep 16, 2024Sep 16 10:54 PMKatherine Stueland
Proposed Sale
10,501$37.59$394.7K

View →

Sep 9, 2024Sep 10 1:03 AMKevin Feeley
Proposed Sale
895$33.33$29.8K

View →

Sep 9, 2024Sep 10 1:03 AMKatherine Stueland
Proposed Sale
3,639$33.33$121.3K

View →

Sep 3, 2024Sep 4 1:35 AMKevin Feeley
Proposed Sale
262$31.71$8.3K

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 11, 2026May 12 12:43 AMCasdin Capital, LLCDirector, 10% Owner
Purchase
50,000850,000(I)

View →

May 8, 2026May 12 12:43 AMCasdin Capital, LLCDirector, 10% Owner
Purchase
300,000800,000(I)

View →

May 7, 2026May 12 12:43 AMCasdin Capital, LLCDirector, 10% Owner
Purchase
500,000500,000(I)

View →

Apr 29, 2026May 1 8:28 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
3,8740(D)

View →

Apr 29, 2026May 1 8:24 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
7540(D)

View →

Mar 26, 2026Mar 30 9:38 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
16,25032,500(D)

View →

Mar 26, 2026Mar 30 9:30 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
80,000160,000(D)

View →

Mar 16, 2026Mar 17 10:40 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
18,75075,000(D)

View →

Mar 15, 2026Mar 17 10:40 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
11,92135,763(D)

View →

Mar 16, 2026Mar 17 10:39 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
7,19728,787(D)

View →

Mar 15, 2026Mar 17 10:39 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
3,81511,446(D)

View →

Mar 9, 2026Mar 11 8:28 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
2,4627,387(D)

View →

Mar 9, 2026Mar 11 8:26 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
6,54619,640(D)

View →

Mar 3, 2026Mar 5 10:50 PMBryan DechairoChief Operating Officer
Grant/Award
10,43010,430(D)

View →

Mar 3, 2026Mar 5 10:49 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Grant/Award
10,86510,865(D)

View →

Mar 3, 2026Mar 5 10:46 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
40,41840,418(D)

View →

Mar 1, 2026Mar 3 9:38 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
7181,434(D)

View →

Feb 1, 2026Feb 4 12:30 AMBryan DechairoChief Operating Officer
Option Exercise
9,37428,123(D)

View →

Jan 29, 2026Feb 2 9:33 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
754754(D)

View →

Jan 29, 2026Feb 2 9:30 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
3,8743,874(D)

View →